Screening for fragile X syndrome: information needs for health planners.
Murray
J
J
Centre for Reproduction, Growth & Development, Research School of Medicine, University of Leeds, United Kingdom.
Cuckle
H
H
Taylor
G
G
Hewison
J
J
D000293:Adolescent; D000328:Adult; D015139:Blotting, Southern; D002648:Child; D002675:Child, Preschool; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D005600:Fragile X Syndrome / Q000188:drug therapy / Q000453:epidemiology* / Q000235:genetics*; D005828:Genetics, Population; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008607:Intellectual Disability / Q000235:genetics; D008297:Male; D008403:Mass Screening / Q000191:economics / Q000379:methods* / Q000523:psychology; D009030:Mosaicism; D009154:Mutation; D015997:Neonatal Screening; D016133:Polymerase Chain Reaction / Q000379:methods; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000009:adverse effects / Q000379:methods; D015995:Prevalence
D005492:Folic Acid